Pfizer (NYSE:PFE) To Divest Entire 7 Percent Stake In Haleon Through Share Offering
Pfizer (NYSE:PFE) announced its intention to sell its entire residual shareholding in Haleon plc, reflecting a divestment strategy that prominently featured an accelerated book building process aimed at institutional investors.
Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.
With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...
Pfizer has exited Haleon through four block trades, the most recent of which was its sale of a 7.7% stake in January at a 2.75% discount. GSK sold its last shares in the company last year. Also on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback